Skip to content

Effect of dry needling technique on spastic upper extremity muscles in patients with chronic ischemic stroke

Effect of dry needling technique on clinical, sonographic and biomechanical parameters of spastic upper extremity muscles in patients with chronic ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200904048609N1
Enrollment
24
Registered
2020-09-23
Start date
2020-11-14
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke. Cerebral infarction

Interventions

Intervention 1: Intervention group: The intervention consists of 12 sessions (4 weeks, 3 sessions per week) routine physiotherapy treatment for stroke patients, including FES and exercise therapy for
And 4 sessions of dry needling treatment on FCU and FCR and FDP muscles once a week. Intervention 2: Control group: The intervention consists of 12 sessions (4 weeks, 3 sessions per week) routine phys
And 4 sessions of sham dry needling treatment on FCU and FCR and FDP muscles once a week.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 35-65 years old Stroke occurrence for first time History of stroke onset at least 6 months and maximum of 2 years prior to the study Spasticity existence in the wrist and fingers flexor muscles ( +1 to 3 based on the modified Ashworth scale) Not taking any antispasmodics during the study for at least one month before the study beginning Having minimal grip ability Ability to understand and follow commands Absence of cognitive impairment (Mini-Mental State Examination score >24)

Exclusion criteria

Exclusion criteria: Recurrent stroke Having other neurological diseases Cervical radiculopathy Fixed contracture in wrist and finger muscles Treatment with other therapies during this study History of physiotherapy treatments in less than a month prior to study History of treatment with dry needling technique after a stroke Previous treatment with nerve blocks or neurolytic agents injection in motor point or Infiltration of botulinum toxin At any time after stroke Uncontrolled hypertension Uncontrolled diabetes Upper limb fracture Any absolute contraindication for using of deep dry needling (such as pregnancy, infection, coagulation defect, seizures or mental disorders, and fear of needles) Reluctance to continue participating in the study

Design outcomes

Primary

MeasureTime frame
Spasticity. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Modified Ashworth scale.;Muscle thickness of FCU, FCR and FDP; Separately for each muscle, and generally for flexor group. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Sonography.

Secondary

MeasureTime frame
Flexor muscles compressibility. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Sonography.;Wrist reflex torque. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Isokinetic machine.;Wrist peak torque. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Isokinetic machine.;Upper limb motor function. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Fugl-Meyer scale.;Upper limb skill. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Box and block test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Panahi

Shiraz University of Medical Sciences

fatemeh.panahi85@gmail.com+98 71 3627 1551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026